NCT01565343View on ClinicalTrials.gov

A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

florbetapir F 18

IV injection, 370MBq (10mCi)

Trial Locations (4)

21901

Research Site, North East

33009

Research Site, Hallandale

33407

Research Site, West Palm Beach

06510

Research Site, New Haven

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY